CYP1A2*1F Polymorphism Decreases Clinical Response to Clozapine in Patients with Schizophrenia


Balibey H., Basoglu C., Lundgren S., BABAOĞLU M. Ö., YAŞAR Ü., Herken H., ...More

KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY, vol.21, no.2, pp.93-99, 2011 (SCI-Expanded) identifier identifier

Abstract

Introduction: Genetic polymorphisms of cytochrome P450 (CYP) may predict the treatment response or occurrence of side effects of antipsychotic drugs.